
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Issues and Controversies in Pharmacoeconomics
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Coronary Heart Disease in the United Statesover 27 years ago
Mechanisms of Acute Coronary Eventsover 27 years ago
Primary Preventionover 27 years ago
Pravastatin Event Reduction Analysisover 27 years ago
Secondary Preventionover 27 years ago
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?over 27 years ago
Methods and Mindsets in Pharmacoeconomicsover 27 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
New Biomarkers, Drug Targets Identified for Colorectal Cancer
3
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
4
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
5